Home › NDC Lookup › Ingredients › Activated Charcoal › 00574-0520-04
ACTIDOSE activated charcoal 208 mg/mL Suspension, 120 mL — NDC 00574-0520-04 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

ACTIDOSE activated charcoal 208 mg/mL Suspension, 120 mL — NDC 0574-0520-04 (Billing 00574-0520-04)

by Padagis US LLC · 120 mL in 1 BOTTLE

This is a package of 120 mL of ACTIDOSE activated charcoal 208 mg/mL Suspension from Padagis US LLC, marketed since Dec 2020 and currently FDA-listed. It is the main listing for this product, which comes in 4 package sizes.

NDC 00574-0520-04
🏷️ FDA NDC (as labeled) 0574-0520-04 billing pads the labeler segment with a zero
This package
Contains120 mL Pack sizes4 compare ↓
Main listing for product 0574-0520 · Also comes in: 120 ml 0574-0520-74 240 ml 0574-0520-08 240 ml 0574-0520-76
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 13, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0574-0520-04 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0574 labeler · 0520 product · 04 package
Listing certified through
Dec 31, 2027
Billing quantity
120 mL per package
Barcode (UPC-A, from the NDC)
3 0574052004 8
FDA record last changed
Aug 13, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0574-0520-04
Product NDC 0574-0520
11-digit billing NDC 00574052004
NCPDP billing unit ML — per mL (volume)
RxCUI 309150, 1251411
UNII 2P3VWU3H10
Application # M023
SPL Set ID 76e4fe6a-afd4-4f68-b12d-0b094f750615
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-12-05
Route ORAL
Dosage form SUSPENSION
Substance ACTIVATED CHARCOAL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 057761
GCN 22989
HICL code 001116
Ingredient (HICL) Activated Charcoal/Sorbitol
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C8
Therapeutic class — intermediate (HIC2) Antidotes To Poisons
HIC3 code C8E
Therapeutic class — specific (HIC3) Antidotes,Miscellaneous
AHFS code 56:04.00.00
AHFS class Antacids And Adsorbents
FDB label name ACTIDOSE 25 GM LIQUID
FDB brand name Actidose
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 057761
  • GCN: 22989
  • HICL (First Databank): 001116
  • AHFS class code: 56:04.00.00
  • RxCUI (RxNorm): 309150
Why two NDCs? The FDA registers this code as 0574-0520-04 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00574-0520-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Charcoal preparations class.

Drug family (ATC) Charcoal preparations
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ACTIDOSE 25 GM LIQUID Ingredient Activated Charcoal/Sorbitol
🧪 What is this product?

Actidose is an oral suspension containing activated charcoal, marketed as an over-the-counter monograph drug. Activated charcoal is typically used in emergency and poison control settings to bind certain ingested substances in the stomach and gastrointestinal tract, potentially reducing their absorption into the bloodstream. This product comes as a liquid suspension for swallowing and is commonly found in first-aid kits and medical facilities.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 120 ml 240 ml 240 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00574-0520-04 You're viewing this Main listing 120 mL in 1 BOTTLE 2020-12-05 — Active
00574-0520-08 0574-0520-08 240 mL in 1 BOTTLE 2021-02-10 — Active
00574-0520-74 0574-0520-74 120 mL in 1 TUBE 2021-02-19 — Active
00574-0520-76 0574-0520-76 240 mL in 1 TUBE 2020-12-05 Dec 31, 2027 Active

Pack size FAQ

What quantity is in this package?
This package contains 120 mL — 120 ml in 1 bottle.
How does this package differ from NDC 00574-0520-74?
Both are ACTIDOSE activated charcoal 208 mg/mL Suspension — the drug itself is identical. This page's package is the 120 mL one, while NDC 00574-0520-74 is the 120 ml package.
What NDC number is used to bill for this package of ACTIDOSE activated charcoal 208 mg/mL Suspension?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Actidose 208 mg/mLthis 00574-0520-04 Padagis 120 ml — — FDA listed —
Actidose Aqua 208 mg/mL 00574-0521-04 Padagis 120 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Dec 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCitric acid, glycerin, propylene glycol, sorbitol, and water.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPadagis US LLC
FDA applicationM023 (OTC MONOGRAPH DRUG)
Labeler code00574
First marketedDec 2020
Product typeHuman Otc Drug
Portfolio63 products on file

More NDCs from Padagis US LLC labeler code 00574

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 9 words ▾

Uses • For emergency use to adsorb swallowed poisons.

⏱️ Dosage and Administration 112 words ▾

Directions Oral dosage: 20 to 30 grams of activated charcoal in a minimum of 8 ounces of liquid or as directed by a health professional. Repeat dose immediately, if possible. 1.

Shake well. 2. Snip tapered tip as indicated in drawing and remove.

Holding the tube upright, carefully cut off tube closure. Reattach tapered tip and connect to any charcoal administration set or squeeze contents in a cup with a minimum of 4 ounces of liquid for patient to drink. 3.

If previous attempts to contact a poison control center, emergency medical facility, or health professional were unsuccessful, continue trying. 4. Keep patient active and moving.

5. Save the container of poison.

⚠️ Warnings 69 words ▾

Warnings • Do not give activated charcoal until after the patient has vomited unless directed by a health professional. • Do not use in persons who are not fully conscious. • Do not use this product, unless directed by a health professional, if turpentine, corrosives (such as alkalies (lye) and strong acids), or petroleum distillates (such as kerosene, gasoline, paint thinner, cleaning fluid or furniture polish), have been ingested.

📦 Storage and Handling 15 words ▾

Other information • Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature]. Do not refrigerate.

🧪 Active Ingredient 7 words ▾

Active ingredient (in each tube) Activated Charcoal

🧪 Inactive Ingredients 10 words ▾

Inactive Ingredients Citric acid, glycerin, propylene glycol, sorbitol, and water.

🎯 Purpose 3 words ▾

Purpose Poison Adsorbent

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Questions or Comments 4 words ▾

Questions? Please call 1-866-634-9120

📄 Package Label / Principal Display Panel 76 words ▾

Package/Label Principal Display Panel NDC 0574-0520-74 ACTIDOSE ® with SORBITOL ACTIVATED CHARCOAL SUSPENSION 25 grams Activated Charcoal 48 grams Sorbitol POISON ADSORBENT If possible call a Poison Control Center, emergency medical facility, or health professional for help before using this product. If help cannot be reached quickly, follow directions on this label. Write emergency phone numbers in space provided.

Emergency Phone Number: WARNING: Cancer and Reproductive Harm – www.P65Warnings.ca.gov. CONTENTS: 120 mL (4 fl oz) label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
240 ml00574-0520-76 36 Rx · $1,289
120 ml this page00574-0520-04 No Medicaid data
240 ml00574-0520-08 No Medicaid data
120 ml00574-0520-74 No Medicaid data
Drug total (last 4 qtrs): 36 Rx · 35 units · $1,289 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Padagis US LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 120 ml (00574-0520-74), 240 ml (00574-0520-08), 240 ml (00574-0520-76). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Padagis US LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00574-0297-01 · Padagis 00574-0521-04 · Padagis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.